Endo to pay $830M to settle pelvic mesh lawsuits

Drug and medical device maker Endo International says it will pay $830 million to resolve roughly 20,000 personal lawsuits from patients who say they were injured by the company's vaginal mesh implants.

The Irish company said in a statement Wednesday that the settlement is subject to a number of conditions and is not an admission of liability.

Tens of thousands of have sued Endo and other device makers over mesh used to repair pelvic collapse in women. Mesh implants were initially pitched to doctors as an improvement over surgery, but the Food and Drug Administration has concluded they carry a higher risk of side effects including pain, and infection.

On Tuesday, the FDA proposed regulating vaginal mesh repair products as "high-risk" medical devices, subject to stricter safety requirements.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA wants stricter safety rules for pelvic mesh

Apr 29, 2014

Makers of trouble-prone implants used to surgically repair women's pelvic problems would be subject to stricter safety requirements under a federal proposal issued Tuesday.

Mesh doesn't up cure rate for vaginal prolapse repair

Sep 12, 2013

(HealthDay)—There are no differences in cure rates after three years of follow-up between women receiving mesh or no mesh for vaginal prolapse repair, according to a study published online Sept. 6 in Obstetrics & ...

Advocacy group seeks ban on pelvic surgical mesh

Aug 25, 2011

(AP) -- A consumer advocacy group is calling on government regulators to ban a type of surgical mesh used to treat pelvic collapse, saying it exposes patients to serious risks.

Recommended for you

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

Safety problems at US germ labs acknowledged

Jul 16, 2014

(AP)—The director of the U.S. Centers for Disease Control and Prevention acknowledged Wednesday that systemic safety problems have for years plagued federal public health laboratories that handle dangerous ...

User comments